Implications of the Human Microbiota for Health and Disease

Human Microbiota Clinical Trial

Official title:

Implications of the Human Microbiota for Health and Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04203303
• Other study ID #: 19-001234
• Status: Recruiting
• Start date: October 3, 2019
• Est. completion date: December 31, 2030

Study information

• Verified date: January 2024
• Source: Mayo Clinic
• Contact: Shahid Karim
• Phone: (507) 422-0763
• Email: Karim.Shahid[@]mayo.edu
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to advance the understanding of human health and disease as it relates to environmental factors that may affect intestinal and non-intestinal microbiota.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 5000
• Est. completion date: December 31, 2030
• Est. primary completion date: October 15, 2030
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 years of age or older

• Able to provide informed consent

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Human Microbiota

Intervention

Other:
• Observational
Observational

Locations

Country	Name	City	State
United States	Mayo Clinic	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Microbiome Differences	compare the relative abundance of specific microorganism groups	10 years

External Links

•   Mayo Clinic Clinical Trials